|
31
|
187
|
6v19B |
Immune receptor complex |
|
14
|
96
|
6vb2B |
Hla-b*15:02 complexed with a synthetic peptide |
|
16
|
100
|
6y2aB |
Crystal structure of hla-b2705 complexed with the nona-peptide mq |
|
34
|
187
|
6v15B |
Immune receptor complex |
|
14
|
100
|
6uzpB |
Hla-b*15:01 complexed with a synthetic peptide |
|
77
|
276
|
6uzoA |
Hla-b*15:02 complexed with a synthetic peptide |
|
79
|
276
|
6vb0A |
Hla-b*15:02 complexed with a synthetic peptide |
|
38
|
187
|
6v1aB |
Immune receptor complex |
|
77
|
276
|
6vb7A |
Hla-b*15:02 complexed with a synthetic peptide |
|
15
|
99
|
6uzmB |
Hla-b*15:02 complexed with a synthetic peptide |
|
79
|
276
|
6uzpA |
Hla-b*15:01 complexed with a synthetic peptide |
|
71
|
275
|
6uz1A |
Noncanonical binding of single-chain a6 tcr variant s3-4 in complex with tax/hla-a2 |
|
43
|
219
|
6t3yB |
Improved high resolution structure of mhc class ii complex |
|
33
|
179
|
6v18A |
Immune receptor complex |
|
16
|
100
|
6vb7B |
Hla-b*15:02 complexed with a synthetic peptide |
|
32
|
180
|
6v1aA |
Immune receptor complex |
|
15
|
100
|
6uzoB |
Hla-b*15:02 complexed with a synthetic peptide |
|
78
|
276
|
6vb1A |
Hla-b*15:02 complexed with a synthetic peptide |
|
72
|
277
|
6vb3A |
Hla-b*15:01 complexed with a synthetic peptide |
|
45
|
225
|
6vtuH |
Dh717.1 fab monomer in complex with man9 glycan |
|
43
|
183
|
6t3yA |
Improved high resolution structure of mhc class ii complex |
|
80
|
276
|
6vb2A |
Hla-b*15:02 complexed with a synthetic peptide |
|
15
|
99
|
6viuB |
Hla-b*15:02 complexed with a synthetic peptide |
|
76
|
276
|
6y2aA |
Crystal structure of hla-b2705 complexed with the nona-peptide mq |
|
15
|
100
|
6uznB |
Hla-b*15:02 complexed with a synthetic peptide |
|
13
|
100
|
6vb3B |
Hla-b*15:01 complexed with a synthetic peptide |
|
40
|
213
|
6vtuL |
Dh717.1 fab monomer in complex with man9 glycan |
|
41
|
187
|
6v18B |
Immune receptor complex |
|
78
|
276
|
6viuA |
Hla-b*15:02 complexed with a synthetic peptide |
|
13
|
100
|
6uz1B |
Noncanonical binding of single-chain a6 tcr variant s3-4 in complex with tax/hla-a2 |
|
78
|
276
|
6uznA |
Hla-b*15:02 complexed with a synthetic peptide |
|
79
|
276
|
6uzmA |
Hla-b*15:02 complexed with a synthetic peptide |
|
15
|
100
|
6vb0B |
Hla-b*15:02 complexed with a synthetic peptide |
|
32
|
177
|
6v15A |
Immune receptor complex |
|
16
|
98
|
7kgpB |
Crystal structure of hla-a*0201 in complex with sars-cov-2 n316-324 |
|
78
|
278
|
7kgtA |
Crystal structure of hla-a*0201 in complex with sars-cov-2 n226-234 |
|
80
|
278
|
7kgpA |
Crystal structure of hla-a*0201 in complex with sars-cov-2 n316-324 |
|
32
|
206
|
7lf5A |
Structure of hyperglycosylated human igg1 fc (fc267) |
|
75
|
276
|
7kgqA |
Crystal structure of hla-a*0201in complex with sars-cov-2 n222-230 |
|
13
|
100
|
6vm9B |
T4h2 t cell receptor bound to hla-a2 presenting gp100t2m peptide (imdqvpfsv) |
|
15
|
98
|
7kgrB |
Crystal structure of hla-a*0201in complex with sars-cov-2 n159-167 |
|
38
|
207
|
7lf9A |
Structure of hyperglycosylated human igg1 fc (fc329) |
|
35
|
207
|
7lfnA |
Structure of hyperglycosylated human igg1 fc (fc267_329) |
|
14
|
100
|
6vm7B |
Silv44 t cell receptor bound to hla-a2 presenting gp100 peptide (itdqvpfsv) |
|
75
|
274
|
7kgrA |
Crystal structure of hla-a*0201in complex with sars-cov-2 n159-167 |
|
15
|
99
|
7kgsB |
Crystal structure of hla-a*0201 in complex with sars-cov-2 n138-146 |
|
15
|
98
|
7kgoB |
Crystal structure of hla-a*0201in complex with sars-cov-2 n351-359 |
|
13
|
100
|
6vmcB |
T4h2 t cell receptor bound to hla-a2 presenting gp100t2l peptide (ildqvpfsv) |
|
11
|
209
|
6xjaA |
Streptococcus pneumoniae iga1 protease with iga1 substrate |
|
78
|
278
|
7kgsA |
Crystal structure of hla-a*0201 in complex with sars-cov-2 n138-146 |
